Brainstorm Cell Stock (NASDAQ: BCLI) stock price, news, charts, stock research, profile.
Open | $0.538 |
Close | $0.540 |
Volume / Avg. | 367.454K / 1.003M |
Day Range | 0.511 - 0.582 |
52 Wk Range | 0.134 - 3.373 |
Market Cap | $34.513M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 2.05% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Brainstorm Cell (NASDAQ: BCLI) through any online brokerage.
Other companies in Brainstorm Cell’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Brainstorm Cell (NASDAQ: BCLI) was reported by Maxim Group on Thursday, September 28, 2023. The analyst firm set a price target for 0.00 expecting BCLI to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Brainstorm Cell (NASDAQ: BCLI) is $0.505 last updated April 22, 2024 at 6:37 PM EDT.
There are no upcoming dividends for Brainstorm Cell.
Brainstorm Cell’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Brainstorm Cell.
Brainstorm Cell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.